# A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa

> **NCT03569371** · PHASE2 · COMPLETED · sponsor: **Incyte Corporation** · enrollment: 10 (actual)

## Conditions studied

- Hidradenitis Suppurativa

## Interventions

- **DRUG:** INCB054707

## Key facts

- **NCT ID:** NCT03569371
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-17
- **Primary completion:** 2019-04-22
- **Final completion:** 2019-04-22
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03569371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03569371, "A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03569371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*